Form D — Janus Henderson Biotech Innovation Fund Ltd
0002131527-26-000001 · filed Jun 9, 2026
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pooled Investment Fund filings
Offering
- Industry
- Pooled Investment Fund
- Exemptions
- 06b, 3C, 3C.7
- Reported offering amount
- —
- Reported amount sold
- $441,173,044
- Minimum investment
- $100,000
- Investors
- 81
- Sales commission
- $0
- Finders' fees
- $0
Issuer
- Name
- Janus Henderson Biotech Innovation Fund Ltd
- CIK
- 2131527
- Entity
- Other
- Jurisdiction
- CAYMAN ISLANDS
- Year incorporated
- 2021
- Address
- C/O MAPLES CORPORATE SERVICES LTD
GRAND CAYMAN, E9 KY1-1104 - Phone
- 345-949-8066
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
N/A Janus Henderson Investors US LLC · PromoterDenver, CO Find on LinkedIn ↗
-
Hugh Ward · DirectorGrand Cayman, E9 Find on LinkedIn ↗
-
Toby Hiscock · DirectorGrand Cayman, E9 Find on LinkedIn ↗
-
Matteo Candolfini · DirectorGrand Cayman, E9 Find on LinkedIn ↗
-
Kenneth Lubbock · DirectorGrand Cayman, E9 Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗